Guardian Pharmacy Services will restrict transfers of approximately 29.9 million Class A shares through September 14, 2027, under agreements with founders, executives and certain employees. The restrictions cover approximately 81% of the approximately 37 million shares held by those pre-IPO holders after the September 27 conversion.

Key Highlights

  • Guardian Pharmacy Services will issue 13,521,396 Class A shares on September 27 through an automatic Class B conversion.
  • The locked-up shares represent approximately 81% of approximately 37 million Class A shares held by relevant pre-IPO holders.
  • Class A shares outstanding will reach 63,320,300 after the September 27 issuance.

Guardian Pharmacy Services, Inc. (NYSE: GRDN) has agreed with founders, executive officers and certain employees to restrict transfers of approximately 29.9 million Class A common shares through September 14, 2027. The restrictions became effective September 10, 2026. Subject to limited exceptions and the company’s prior consent, the covered holders cannot offer, sell, distribute, dispose of or transfer the approximately 29.9 million Class A shares during the lock-up period. The agreements apply to founders, executive officers and certain other employees. Those holders are collectively subject to the restrictions after giving effect to the planned issuance connected with the final Tranche of Class B common stock issued during Guardian Pharmacy Services’ reorganization in September 2024.

September 27 Conversion Sets Share Count

The automatic conversion will issue 13,521,396 Class A common shares on September 27, 2026. Guardian Pharmacy Services said the locked-up shares will account for approximately 81% of the approximately 37 million Class A shares held by founders, executive officers and other employees who owned common stock before the initial public offering. The company expects to have 63,320,300 Class A common shares outstanding after the conversion and issuance. The lock-up agreements remain in effect through September 14, 2027, subject to the stated exceptions and consent provision.